Dilaudid

Fresenius Kabi USA, LLC🇺🇸 United States

FDA Page

Effective Date: Jul 15, 2026
Approval ID: 9eebd88a-5632-460f-b7b6-26c8a180540d
Products: 3 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DILAUDID INJECTION safely and effectively.See full prescribing information for DILAUDID INJECTION.DILAUDID INJECTION (hydromorphone hydrochloride) for intravenous, intramuscular, or subcutaneous use, CII Initial U.S. Approval: January 1984

Quick Stats

Total Products3

Labelers2

Label Sections30

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.